• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Norway

dkNET community events and announcements in March, 2023

  • 04:36pm March 10, 2023
  • Ko-Wei Lin

Dear dkNET Community,

dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.


dkNET News

  • dkNET Office Hours Are you ready for the new NIH Data Management and Sharing Plan (effective January 25, 2023)? Do you have questions or need help? Attend dkNET Office Hours on Friday, Mar. 3, 2023, 11 am - 12 pm PT! Dr. Jeffrey Grethe, dkNET co-PI and expert on Data Management and Sharing, Dr. Rebecca Rodriguez, the Repository Program Director at NIDDK, Ms. Reaya Reuss, Chief of Staff to the Deputy Director at NIDDK, and the support team members from the NIDDK Central Repository, will be available to answer your questions. Link: https://dknet.org/about/blog/2585


  • Upcoming dkNET Webinars: dkNET New Investigator Pilot Program in Bioinformatics Awardee Webinar Series (1) “Estimating Relative Beta-Cell Function During Continuous Glucose Monitoring” presented by Dr. Joon Ha on Friday, Mar. 10, 2023, 11 am - 12 pm PT: https://dknet.org/about/blog/2589 (2) “Single Molecule Spatial Transcriptomics: Interpreting the Spatial Expression of RNAs from FISH Images” presented by Dr. Jing Liu on Friday, Apr. 21, 2023, 11 am - 12 pm PT: https://dknet.org/about/webinar


  • Recordings and Slides are Now Available: (1) dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sharing Mandates" on Jan. 13, 2023: Slides; Recording. (2) FAIR Data Curation of Antibody/B-cell and T-cell Receptor Sequences in the AIRR Data Commons on Jan. 27, 2023: Slides; Recording. (3) Choosing Sample Sizes for Multilevel and Longitudinal Studies Analyzed with Linear Mixed Models on Feb. 10, 2023: Slides; Recording. (4) dkNET Pilot Program Awardee Webinar Series “Postpartum Glucose Screening Among Homeless Women with Gestational Diabetes” on Feb. 24, 2023: Slides; Recording.




  • The 2023 dkNET Summer of Data Student Program is a 6-week program providing an opportunity for students (high school to Masters/ PhD graduate) to learn rigor and reproducibility practices, FAIR data management, & dkNET resources and apply them to their research projects! dkNET is accepting applications now! This program requires that students be involved with an NIDDK-related research lab during the summer of 2023. dkNET offers limited scholarships to student applicants. Application due date: Apr. 24, 2023.





    • airr_tools (RRID:SCR_023297) is a GitHub repository for the paper "T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases" by Høye et al.


Events in March 2023

Mar. 03, 2023

dkNET Office Hours - "Are You Ready for 2023: New NIH Data Management and Sharing Mandates" on March 3, 2023

For all proposals submitted on/after January 25 2023, NIH requires data sharing from all NIH-funded studies. Do you have appropriate data management practices and sharing plans in place to meet these requirements? Have questions or need some help? Join the dkNET office hours to learn about NIH’s policy (NOT-OD-21-013) and available resources that could help.

In our upcoming session on March 3, 2023, we are pleased to invite Dr. Jeffrey Grethe, dkNET co-PI and expert on Data Management and Sharing, Dr. Rebecca Rodriguez, Repository Program Director at NIDDK, Ms. Reaya Reuss, Chief of Staff to the Deputy Director at NIDDK, and the support team members from the NIDDK Central Repository. They will be available to answer any questions you may have.

More information: https://dknet.org/about/blog/2585


Mar. 08-09, 2023

NIDDK Unraveling the Secrets of the (Renal) Interstitium Webinar

Meeting Objects:
  • Define the current state of the field.
  • Define the physiological significance of the renal interstitium and its role in modulating renal function.
  • Leverage knowledge from other organs to identify knowledge gaps and research opportunities.
  • Identify the need for developing novel tools and technologies for imaging and interrogating the interstitium.
  • Define a framework for moving the field forward.

Registration deadline: March 7, 2023

More information: https://www.niddk.nih.gov/news/meetings-workshops/2023/unraveling-the-secrets-of-the-renal-interstitium


Mar. 08, 2023

Diabetes Research Virtual Seminar Series: What Goes Wrong with the Beta Cells in Diabetes?

Speaker: Susan Bonner-Weir, PhD (Harvard/Joslin).

More information: https://diabetes-virtual-seminar.org/

Mar. 10, 2023

dkNET Webinar: Estimating Relative Beta-Cell Function During Continuous Glucose Monitoring and Its Clinical Applications

dkNET New Investigator Pilot Program in Bioinformatics Awardee Webinar Series

Join dkNET Webinar on Friday, March 10, 2023, 11 am - 12 pm PST

Presenter: Joon Ha, PhD. Associate Professor, Department of Mathematics, Howard University, Washington DC.

Abstract 

The most common form of diabetes, type 2 diabetes (T2D) is a failure of insulin-secreting pancreatic beta-cells to increase insulin to the level required to maintain normal blood glucose. Thus, identifying beta-cell function and insulin sensitivity in those who are at high risk is crucial to preventing and delaying the disease. Hyper-glycemic clamp and euglycemic hyper- insulinemic clamp are considered to be gold standard measures for these quantities. However, these two methods demand highly skilled labor and thus are cost-prohibitive. Glucose challenge tests have been used to estimate beta-cell function and insulin sensitivity. The product of beta-cell function and insulin sensitivity, termed the disposition index (DI), is of great value because it measures beta-cell function relative to insulin requirements. However, glucose challenge tests are expensive and time-consuming and therefore impractical to implement in large-scale clinical studies. To address this challenge, we developed a model disposition index (mDI estimated without insulin) that does not require insulin measurements during an oral glucose tolerance test (OGTT) (Ha et al., Diabetes 2021 (70) suppl. 1). mDI outperforms the conventional oral disposition index (oDI) at predicting progression to diabetes.

To further increase access and refine the assessments of beta-cell function, we are adapting our model to calculate a model disposition index using continuous glucose monitoring (CGM). CGM has been in the spotlight of diabetes management and has revolutionized the field of medicine as they are approved for glucose monitoring and clinical decision-making in patients with diabetes. CGM devices are relatively inexpensive compared to oral glucose challenge tests, accessible, and simple to use, especially in remote or free-living environments. The CGM device continuously measures interstitial glucose every 5 minutes and provides glucose profiles for 7-14 days. Thus, there are numerous data points compared to glucose challenge tests, but the abundant data points have not previously been used for estimating metabolic parameters. We compared mDI to two widely used CGM-derived metabolic parameters for assessing metabolic status and risk, mean glucose and glycemic excursion. Both mean glucose and glycemic excursion correlated strongly with mDI. The new approach promises to be cost- effective and easy to perform and therefore implementable in large-scale clinical studies. As for specific clinical applications, estimated model parameters during OGTTs identified ethnic differences in common pathways to T2D between Pima Indians and Koreans.

More information: https://dknet.org/about/blog/2589



Mar. 12-17, 2023

Gordon Research Conference: Examining the Intersection Between Systemic and Cellular Metabolism and Lifestyle Factors to Understand Health and Disease

The Metabolomics and Human Health GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field. Metabolomics is the comprehensive study of the metabolome, the repertoire of metabolites present in cells, tissues, and body fluids. More recently, these metabolites are being implicated in the promotion of human health. The human metabolic profile is influenced by a number of factors including diet, genetics, environmental factors and the microbiome. Understanding the influence of these factors at a cellular and systemic level is key to deciphering the role of metabolites in human health and promotion of lifespan.In this Gordon Conference series, we highlight state of the art metabolomics technologies and how such technologies can be used to study Human health. The conference will cover exciting new applications in the field such as Precision Nutrition, Human Ageing, response to Therapies (Precision Medicine), Exposome and Human Health. Application deadline: Feb. 12, 2023.

Location: Lucca, 55100 Lucca, Province of Lucca, Italy

More information: https://www.grc.org/metabolomics-and-human-health-conference/2023/ 

Mar. 19-23, 2023

Keystone Symposia: Metabolic and Molecular Mechanisms of NAFLD/NASH

Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) represents the hepatic manifestation of the Metabolic Syndrome and is emerging as a key driver of morbidity and mortality, particularly when present in the context of severe liver fibrosis. The histological hallmarks of NASH including steatosis, lobular inflammation and hepatocyte ballooning are well-characterized, however while it is widely recognized that NASH is a progressive disease, the pathogenic and molecular mechanism/s that initiate and drive NASH remain largely unknown. The primary purpose of this meeting is to bring together a broad group of scientific and clinical researchers to highlight and discuss the current evidence exploring the key biological processes involved in NASH and liver fibrosis. Insulin resistance, hepatocyte lipid management/lipotoxicity and inflammation in the context of steatosis and NASH will be reviewed. Advances in our understanding of the molecular and genetic regulation of NAFLD/NASH and the progression to liver fibrosis will also be highlighted. Finally, as NASH is an unmet medical need, we will integrate the earlier fundamental biology discussion with updates on clinical progress of therapeutic agents, and combinations of agents, for the treatment of NASH and liver fibrosis. The parallel joint meeting with one focused on key cellular drivers and mediators of fibrosis in organs beyond the liver allows for cross-functional discussion and deeper understanding of pathobiology of fibrotic disease.

Location:  Banff, AB, Canada

More information: https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=6913


Mar. 27, 2023

NIDDK NMRI Annual Workshop 2023

The meeting is open to all underrepresented minority investigators, including post-graduate doctoral students, who are conducting biomedical research in the fields of:
  • Diabetes, endocrinology, metabolism
  • Digestive and liver diseases, nutrition
  • Kidney, urologic, and hematologic diseases
Registration deadline: April 3, 2023
Meeting dates: April 19-21, 2023

Location:  Bethesda, MD, USA

More information: https://www.niddk.nih.gov/news/meetings-workshops/2023/nmri-annual-meeting-2023


Mar. 29, 2023

NLM Training: Standardize Your Research with the NIH Common Data Element Repository

Through live demonstrations and hands-on exercises, this course will introduce you to common data elements (CDEs) and the NIH Common Data Element Repository (CDE-R). The course begins with an in-depth introduction to what CDEs are and examples of how researchers are already using them. Then, you’ll see how to search the repository and practice searching on your own. Subject matter experts will be in attendance to answer your questions.

Consider attending this course if you:

  • Want to standardize the data you collect so it can be easily shared with colleagues and other researchers
  • Have been awarded a grant that requires the use of CDEs
  • Have heard that CDEs can be part of a compliant data management and sharing plan
  • Assist researchers with the research data management lifecycle

More information: https://nih.zoomgov.com/webinar/register/WN_ZEGtd7yUR7uyIhCvh9GupQ



Funding Opportunities Information and Deadlines in March 2023

Mar. 01, 2023

HHMI Funding Opportunity Application Deadline: The Howard Hughes Medical Institute (HHMI) Opens National Competition for Investigator Program

The Howard Hughes Medical Institute (HHMI) is announcing a national open competition to appoint approximately 25 new Investigators. This effort will expand HHMI’s community of more than 260 Investigators who perform basic biological research at about 60 research institutions across the nation. Each HHMI Investigator will receive roughly $8 million over a seven-year term, which is renewable pending favorable scientific review. HHMI encourages Investigators to push their research fields into new areas of inquiry.

More information: https://www.hhmi.org/news/hhmi-opens-national-competition-investigator-program

Mar. 01, 2023

NIH Funding Opportunity Application Due: Enhancing the Use of the All of Us Research Program’s Data (R21 Clinical Trial Not Allowed)

The All of Us Research Program (All of Us) within the Office of the Director (OD) encourages investigators to apply for grant awards that will advance research in high-priority mission areas of the Institutes, Centers, and Offices (ICOs) through two companion FOAs (1) one to use standard methods and approaches to analyze currently available data within the All of Us Research Program’s Researcher Workbench and (2) one to develop new methods, models, and tools and use them to analyze data in the Researcher Workbench. The new tools will be made broadly available to the scientific community. This FOA uses the R21 grant mechanism for new tool development and application, while the companion FOA (link) uses the R03 grant mechanism to support data analysis using standard methods. Application Due Date: Mar. 1, 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-pm-23-001.html

Mar. 01, 2023

NIH Funding Opportunity Application Due: Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed)

The All of Us Research Program (All of Us) within the Office of the Director (OD) encourages investigators to apply for grant awards that will advance research in high-priority mission areas of the Institutes, Centers, and Offices (ICOs) through two companion FOAs (1) one to use standard methods and approaches to analyze currently available data within the All of Us Research Program’s Researcher Workbench and (2) one to develop new methods, models, and tools and use them to analyze data in the Researcher Workbench. The new tools will be made broadly available to the scientific community. This FOA uses the R03 grant mechanism to support data analysis using standard methods, while the companion FOA (link) uses the R21 mechanism for new tool development and application. Application Due Date: Mar. 1, 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-pm-23-002.html


Mar. 02, 2023

NIDDK Funding Opportunity Application Due: NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)

The NIDDK Central Repository houses valuable biological samples and data from numerous major clinical studies. This initiative allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples available can be found at the Repository's website. Applicants must include a volume and impact assessment report from the NIDDK Central Repository with the X01 Application to document sample availability.
Letter of Intent Deadline: 30 days prior
Application Deadline: October 27, 2022 ; March 2, 2023 (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-171.html


Mar. 07, 2023

NIH Funding Opportunity Application Due: HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain (R01 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) invites research to develop, characterize, and rigorously validate non-rodent mammalian models of pain, associated outcome measures and/or endpoints that will significantly advance translational research for effective pain management. These models are expected to recapitulate molecular, cellular, pathological, behavioral, and/or cognitive aspects of human pain disorders and conditions. Research supported under this FOA is expected to provide well-validated models and measures that facilitate the development of non-opioid analgesic therapeutic interventions with little or no addiction liability.
Letter of Intent Deadline: 30 days prior to the application due date
Application Deadline(s): November 04, 2022 ; March 07, 2023 ; (...)
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-ns-22-070.html


Mar. 08, 2023

NIDDK Funding Opportunity Application Due: Fostering Research With Additional Resources and Development (FORWARD) Urology Centers

The overall goal of the Fostering Research with Additional Resources and Development (FORWARD) Urology Centers program is to foster and expand the urology (excluding cancer) research community. The objective of each FORWARD Urology Center will be to support a Research Project designed and conducted by a collaborative, multidisciplinary team comprising primarily of junior investigators with at least one Early Stage Investigator (ESI) and/or researcher new to urology. Research Project data are expected to support one or more follow-on independent grant applications (e.g., R01s) submitted by Research Project Team investigators. The Center PD(s)/PI(s) will lead an Administrative (Project Support) Core to provide guidance to the Research Project Team to help ensure the research aims are met and to aid them in their successful integration into the broader urologic research field. The Center will leverage intra- and extra-institutional resources, collaborations and facilities and engage as a member of NIDDK’s CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology) Program. Letter of Intent Due Date: February 8, 2023; Application Due Date: March 8, 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-027.html



Mar. 09, 2023

NIH Funding Opportunity Application Due: HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain transduction, transmission, and processing. This FOA will support concerted multidisciplinary team science efforts that apply large-scale high-throughput approaches on tissues involved in human pain processing as part of the NIH HEAL Initiative’s Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain). U19 Centers will operate as a cooperative network to promote collaboration and coordination of research activities. U19 Centers will also coordinate with the U24 HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center that will curate, harmonize, and integrate datasets generated by this U19 research program.
Letter of Intent Deadline: 30 days prior to the application due date
Application Deadline: March 17, 2022 ; July 7, 2022 ; October 11, 2022 ; March 09, 2023
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-ns-22-018.html

Mar. 09, 2023

NIDDK Funding Opportunity Application Due: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Not Allowed)

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), in collaboration with the International IBD Genetics Consortium, has identified over 250 susceptibility loci for inflammatory bowel disease (IBD). The IBDGC was renewed recently with a continued mission to characterize the genetic architecture of IBD phenotypes in diverse populations and to elucidate the biological mechanisms by which genetic variants influence IBD pathophysiology and clinical course. However, current resources permit functional investigation of only a limited number of loci, genes and physiological domains, while the biological mechanisms underlying most of the identified IBD risk loci remain unknown. The purpose of this Funding Opportunity Announcement (FOA) is to expand the number of IBD susceptibility loci, causal variants and effector genes, and IBD-related phenotypes and physiological domains under investigation via Ancillary Studies utilizing the extensive resources, including subjects, samples and datasets, established by the IBDGC. Proposed Ancillary Studies should focus on causal variant identification and/or functional characterization of effector genes within IBD risk loci and must not duplicate studies that are either ongoing or already completed by the IBDGC. Application Due Date: Mar. 9 , 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-023.html




Mar. 17, 2023

NIH Funding Opportunity Letter of Intent Due: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. Letter of Intent Due Date: March 17, 2023; Application Due Date: April 17, 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-od-23-003.html


Mar. 20, 2023

NIDDK Funding Opportunity Letter of Intent Due: New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)

The New Investigator Gateway Award in T1D Research is designed to support a robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives.
Letter of Intent Deadline(s): May 1, 2022 and February 20, 2023
Application Deadline (New Application): June 1, 2022 and March 20, 2023
More Information: https://dknet.org/about/dknetnews/2379

Mar. 24, 2023

NIH Funding Opportunity Application Due: Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)

This initiative will support intervention research that addresses structural racism and discrimination (SRD) in order to improve minority health or reduce health disparities. Application Due Date: Mar. 24, 2023.

More information: https://grants.nih.gov/grants/guide/pa-files/par-23-112.html


Mar. 24, 2023

NIH Funding Opportunity Application Due: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable. Application Due Date: Mar. 24, 2023.

More information: https://grants.nih.gov/grants/guide/rfa-files/rfa-md-23-003.html [less]

This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose t ...[more]


Mar. 30, 2023

NIDDK Funding Opportunity Application Due: KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)


The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Transition Award (F99/K00) is to recruit truly exceptional graduate students, who are currently not involved in Kidney, Urology or Hematology (K, U or H) research, and provide them a stable transition into a postdoctoral research experience focused on K, U, or H research. Strong candidates will bring novel approaches and diverse perspectives from fields including, but not limited to, engineering, statistics, data science, imaging, biochemistry, neuroscience and genetics. Graduate students who are already involved in K, U, or H research are not eligible for this F99/K00 award and are instead encouraged to apply for the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31, PA-21-051). Prospective applicants are strongly encouraged to contact the NIDDK Program Official early in the process to discuss eligibility and program goals.
Application Deadline: August 1, 2022; November 30, 2022; March 30, 2023 (...)
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-21-033.html

Mar. 31, 2023

NIDDK Funding Opportunity Application Due: Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications to develop a centralized resource of the human pancreas for diabetes research that will provide access to deeply curated high-quality datasets, knowledge in computable forms, and advanced data science tools and workflows; and enable open and reproducible multidisciplinary collaboration toward accelerating biomarker and therapeutic target development. The program will become a component of the Human Islet Research Network or HIRN (https://hirnetwork.org/).Letter of Intent Due Date: February 28, 2023. Application Due Date: March 31, 2023. 
More Information: https://dknet.org/about/dknetnews/2497

Mar. 31, 2023

NIDDK Funding Opportunity Application Due: NIDDK Information Network Coordinating Unit: dkNET-CU

The purpose of this FOA is to continue the development and expansion of the NIDDK Information Network (dkNET) under the direction of the dkNET Coordinating Unit (dkNET-CU). dkNET supports the NIDDK community’s needs in data science by providing an information portal that connects users to data, analytical tools, and other biomedical research resources. Additionally, dkNET supports researchers by providing a hub for data-driven hypothesis generation; a suite of tools that assist users in FAIR (Findable, Accessible, Interoperable, Reusable) practice, and in improving rigor and reproducibility in research; and a variety of programs to enhance community engagement and workforce development. The dkNET-CU will be responsible for providing the scientific direction, vision, and administrative management to advance dkNET goals. Letter of Intent Due Date: February 28, 2023; Application Due Date: March 31, 2023.

More information: https://dknet.org/about/dknetnews/2527

Search

Recent dkNET Blog

dkNET Webinar: Single Cell Multi-Omics Analysis of Beta Cell Heterogeneity and Differentiation

dkNET community events and announcements in May, 2024

[Slides are Available Now!] dkNET Webinar "The 4DN Data Portal - Data, Resources and Tools to Help Elucidate Nuclear Organization in Space and Time"

dkNET Blog Tags

About

The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.

Recent News Entries

dkNET Webinar: Single Cell Multi-Omics Analysis of Beta Cell Heterogeneity and Differentiation

Funding Opportunity: HTORR Pilot Award Program

dkNET community events and announcements in May, 2024

Contact Us

Email: info_at_ dknet.org

Stay Connected

About SciCrunch | Privacy Policy | Terms of Service

SciCrunch
X

Are you sure you want to delete that component?